NCT/Study#

NCT03873883 /

IO-001

Phase I/Ib First-in-Human study of EOS100850 in patients with advanced solid tumors

Phase I/Ib First-in-Human study of EOS100850 in patients with advanced solid tumors

DISEASE GROUP:
Phase 1
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: